• Join
  • Login
  • Contact

Search abstracts

Implications in pharmaceutical practice by using nanomedicines

  • At: AbuDhabi (United Arab Emirates) (2019)
  • Type: Presentation
  • By: STEMER, Gunar (Vienna General Hospital - Medical University, Austria)
  • Abstract:

    Pharmacists are key stakeholders when it comes to selecting and evaluating drugs for inclusion in healthcare institutions’ formularies. Nanomedicines are diverse and heterogeneous products with a higher level of complexity regarding their assessment and evaluation. A profound knowledge of important characteristics is therefore necessary for all


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses